I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine (Seqirus) and plasma therapy (Behring ...
Let's see if analysts think investors should be buying the dip with this quality stock. The post CSL is approaching a 5-year ...
Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s ...
The CSL Ltd (ASX: CSL) share price is down 1.6% to $255.51 per share, while the S&P/ASX 200 Index (ASX: XJO) is trading in ...
Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue growth outlook” and margin ...
CSL Limited ( ASX:CSL ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be ...
Atlas Funds’ Phil Cornet says the weakness in the ASX 200 heavyweight makes no sense and Ampol is ripe for a rally.
CSL shares will pay a 9% higher interim dividend of US$1.30 per share on 9 April. Here's when the ASX healthcare giant will go ex-dividend.
CSL Limited (ASX:CSL) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be two business days before the record date, which is the cut-off date on which you must ...